Detalhe da pesquisa
1.
Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics.
Mol Syst Biol
; 20(1): 28-55, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177929
2.
Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors.
Nat Chem Biol
; 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904048
3.
An Introduction to Analytical Challenges, Approaches, and Applications in Mass Spectrometry-Based Secretomics.
Mol Cell Proteomics
; 22(9): 100636, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37597723
4.
Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics.
Nat Biotechnol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714896
5.
Structural Basis for Highly Selective Class II Alpha Phosphoinositide-3-Kinase Inhibition.
J Med Chem
; 66(20): 14278-14302, 2023 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819647
6.
Decrypting drug actions and protein modifications by dose- and time-resolved proteomics.
Science
; 380(6640): 93-101, 2023 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36926954